Epigenica 🇸🇪
Stockholm high-throughput epigenetic screening tools (EpiFinder)
About Epigenica
The main product is a high-throughput multiplexed ChIP-seq platform that facilitates comprehensive epigenetic profiling by allowing simultaneous analysis of multiple epigenetic markers across various samples with minimal input material. This technology combines workflows for DNA methylation and histone post-translational modifications, improving the efficiency and scalability of epigenetic research.
Epigenica is a Sweden-based company founded in 2020, now around 19 people. It has raised $2.2M in disclosed funding.
Founded by Mohamad Takwa (CEO & Co-Founder; repeat founder; previously Avsalt AB, Bioextrax AB; KTH Royal Institute of Technology), Simon Elsässer (Co-Founder; previously BIFonds, Lindau Nobel Laureate Meeting; Rockefeller University).
Its investors also appear on FundFinder's most-active lists for Seed · AI (93 funds), Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · $2.2M · Jun 2025
- Almi Invest — Almi Invest is the state-owned Swedish venture investor within the Almi Group and calls itself Sweden's most active startup investor. · cheques £75k – £300k
- Voima Ventures — Helsinki deep tech VC with an office in Stockholm. · cheques £170k – £2.5M
- Wallenberg Investments (Navigare Ventures) — Wallenberg Investments' Ventures unit was launched in 2021 as Navigare Ventures, a wholly owned Stockholm-based subsidiary of Wallenberg Investments AB.